- Home
- CRDF vs NVNI Comparison
CRDF vs NVNI Comparison
Compare CRDF & NVNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- NVNI
- Stock Information
- Founded
- CRDF 1999
- NVNI 2019
- Country
- CRDF United States
- NVNI Brazil
- Employees
- CRDF N/A
- NVNI N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- NVNI
- Sector
- CRDF Health Care
- NVNI
- Exchange
- CRDF Nasdaq
- NVNI Nasdaq
- Market Cap
- CRDF 288.7M
- NVNI 10.4M
- IPO Year
- CRDF N/A
- NVNI N/A
- Fundamental
- Price
- CRDF $4.19
- NVNI $0.25
- Analyst Decision
- CRDF Strong Buy
- NVNI
- Analyst Count
- CRDF 4
- NVNI 0
- Target Price
- CRDF $12.00
- NVNI N/A
- AVG Volume (30 Days)
- CRDF 1.1M
- NVNI 17.9M
- Earning Date
- CRDF 05-01-2025
- NVNI 05-07-2025
- Dividend Yield
- CRDF N/A
- NVNI N/A
- EPS Growth
- CRDF N/A
- NVNI N/A
- EPS
- CRDF N/A
- NVNI N/A
- Revenue
- CRDF $683,000.00
- NVNI $23,558,620.00
- Revenue This Year
- CRDF N/A
- NVNI $25.91
- Revenue Next Year
- CRDF N/A
- NVNI $17.52
- P/E Ratio
- CRDF N/A
- NVNI N/A
- Revenue Growth
- CRDF 39.96
- NVNI 38.59
- 52 Week Low
- CRDF $2.01
- NVNI $0.22
- 52 Week High
- CRDF $6.42
- NVNI $12.19
- Technical
- Relative Strength Index (RSI)
- CRDF 48.00
- NVNI 28.08
- Support Level
- CRDF $3.52
- NVNI $0.22
- Resistance Level
- CRDF $4.31
- NVNI $0.33
- Average True Range (ATR)
- CRDF 0.36
- NVNI 0.36
- MACD
- CRDF -0.07
- NVNI -0.18
- Stochastic Oscillator
- CRDF 28.57
- NVNI 1.09
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").
About NVNI Nvni Group Limited
Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.